Amgen director awarded additional common shares

HOLLEY CHARLES M reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

HOLLEY CHARLES M reported acquisition or exercise transactions in this Form 4 filing.

Amgen Inc. director Charles M. Holley reported updated equity holdings. On May 5, 2026, he received a grant or award of 128.9481 shares of Amgen common stock at no cash cost, increasing his direct ownership to 12,134.0331 shares.

He also reports indirect ownership of 1,260 shares through the Holley Family Trust. The reported holdings include 1,564 Dividend Equivalents credited to his unvested Restricted Stock Units, which are payable in Amgen common stock on a one-for-one basis as those units vest.

Insider Trade Summary

Grant/Award: 128.9481 shares

Grant/Award 2 txns

Insider HOLLEY CHARLES M

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	128.9481	$0.00	$0.00
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 12,134.0331 shares (Direct); Common Stock — 1,260 shares (Indirect, Holley Family Trust)

Footnotes (1)

1. F1. These shares include 1,564 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

Key Figures

Stock award: 128.9481 shares Direct holdings after award: 12,134.0331 shares Indirect holdings: 1,260 shares +2 more

5 metrics

Stock award 128.9481 shares Common Stock grant to Charles M. Holley on May 5, 2026

Direct holdings after award 12,134.0331 shares Amgen common stock directly owned following the reported grant

Indirect holdings 1,260 shares Amgen common stock held through the Holley Family Trust

Dividend Equivalents 1,564 units Dividend Equivalents tied to unvested RSUs, payable in common stock

Award price per share $0.0000 per share Reported price for the 128.9481-share grant

Key Terms

Dividend Equivalents (DEs), Restricted Stock Units, Equity Incentive Plan, grant, award, or other acquisition

4 terms

Dividend Equivalents (DEs) financial

"These shares include 1,564 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended..."

Restricted Stock Units financial

"DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares..."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Equity Incentive Plan financial

"Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan..."

An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.

grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the latest Amgen (AMGN) Form 4 filing show for Charles M. Holley?

The Form 4 shows director Charles M. Holley reported an additional stock award and updated holdings. He received 128.9481 Amgen common shares and now directly owns 12,134.0331 shares, plus indirect ownership of 1,260 shares through the Holley Family Trust.

How many Amgen (AMGN) shares were granted to Charles M. Holley in this filing?

Charles M. Holley received a grant or award of 128.9481 shares of Amgen common stock at a reported price of $0.0000 per share. This reflects a compensation-related stock award rather than an open-market purchase, increasing his direct share position.

What are Charles M. Holley’s total reported Amgen (AMGN) shareholdings after the Form 4?

After the reported transactions, Charles M. Holley directly holds 12,134.0331 Amgen common shares. He also has indirect ownership of 1,260 shares through the Holley Family Trust, giving him combined reported holdings across direct and indirect accounts in the filing.

What is the Holley Family Trust’s role in Charles M. Holley’s Amgen (AMGN) holdings?

The Holley Family Trust holds 1,260 Amgen common shares reported as indirect ownership for Charles M. Holley. This means those shares are owned through the trust structure rather than in his personal name, but they are still disclosed as part of his overall position.

How are Dividend Equivalents treated in Charles M. Holley’s Amgen (AMGN) equity awards?

The filing notes 1,564 Dividend Equivalents granted under Amgen’s equity incentive plan. These are credited to Holley’s unvested Restricted Stock Units and are paid out in Amgen common stock on a one-to-one basis as the RSUs vest, with cash paid for fractional amounts.

Are the new Amgen (AMGN) shares for Charles M. Holley an open-market purchase?

No. The 128.9481 Amgen common shares are reported with transaction code “A,” indicating a grant, award, or similar acquisition. The price is shown as $0.0000 per share, consistent with compensation-related stock awards rather than a market transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/07/2026 - 08:38 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HOLLEY CHARLES M

(Last) (First) (Middle)

ONE AMGEN CENTER DRIVE

(Street)

THOUSAND OAKS CALIFORNIA 91320

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AMGEN INC [ AMGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/05/2026		A		128.9481	A	$0	12,134.0331(1)	D
Common Stock								1,260	I	Holley Family Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares include 1,564 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

	/s/ Charles M. Holley	05/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)